Therapy Discontinuation after Myocardial Infarction

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Discontinuation of recommended pharmacotherapy after myocardial infarction (MI) increases the risk of thrombotic complications.
• Understanding nonadherence patterns is crucial for improving patient outcomes post-MI.

Purpose of the Study:

• To comprehensively analyze short- and long-term pharmacotherapy discontinuation in post-MI patients.
• To identify determinants of medication nonadherence within one year of MI.

Main Methods:

• A single-center cohort clinical trial with 225 post-MI patients and one-year follow-up.
• Analysis of therapy initiation, short-term (<30 days), long-term (≥30 days), and permanent discontinuation using prescription filling data.

Main Results:

• Occupational activity and prior MI predicted lack of P2Y12 inhibitor initiation.
• Older age (>65 years) and prior revascularization predicted overall therapy discontinuation.
• No independent predictors for simultaneous cessation of all medications were identified.

Conclusions:

• A majority of post-MI patients discontinue at least one essential medication within a year.
• Statins are the most frequently discontinued medication class.
• Older age and prior cardiac revascularization are key determinants of medication discontinuation.